Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cybin Inc (NY: CYBN )

0.2925 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Psychedelic Stock Gainers And Losers From January 23, 2023
 
Via Benzinga
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different... 
Via Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Cybin Touts Promising Results From Sponsored Kernel Flow Study Measuring Psychedelic Effects On The Brain
Cybin Inc. 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023
 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Promising Results from Kernel Flow(R) Feasibility Study
Via Investor Brand Network
Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain
From Cybin Inc.
Via Business Wire
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January. 
Via Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
Life sciences biotech company Cybin Inc. (NYSE: CYBN) announced its selection of the Generalized Anxiety Disorder (GAD) with or without Major Depressive Disorder (MDD) as the target indication for its... 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
A "Multi-Bagger" Portfolio For 2023 - Introduction
I am optimistic that the market will perform better in 2023 so I've put together a basket of 10 stocks that could well realize multi-bagger returns this year. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From January 13, 2023
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Selects Generalized Anxiety Disorder as Target Indication for CYB004
Via Investor Brand Network
Cybin Selects Generalized Anxiety Disorder as Target Indication for Deuterated DMT Molecule CYB004
From Cybin Inc.
Via Business Wire
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine... 
Via Benzinga
Why Lightning eMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket
Gainers Broadwind, Inc. (NASDAQ: BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine... 
Via Benzinga
Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans
It’s the beginning of 2023 and psychedelics companies are updating the public on their developmental and clinical progress as well as their selected milestones for the year. 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 9, 2023
 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Status Update on Clinical Development Programs
Via Investor Brand Network
Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs
From Cybin Inc.
Via Business Wire
Psychedelic Stock Gainers And Losers From January 3, 2023
 
Via Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
What a year for psychedelics! 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.